Search control section

More than 500 beds
This hospital has an emergency department
This is a public hospital

Royal Prince Alfred Hospital

Left hand navigation section

Safety & quality

Healthcare-associated infections

Staphylococcus aureus (S. aureus or ‘Golden staph’) is a type of bacterium that can cause an infection of the bloodstream and can be acquired after a patient receives medical care or treatment in hospital. Contracting an S. aureus bloodstream infection while in hospital can be life-threatening. Hospitals aim to have as few cases as possible.

The data presented below show S. aureus bloodstream infections that were found to have been acquired while receiving care at this hospital.

All healthcare-associated S. aureus bloodstream infections

In 2017–18, there were 38 cases reported during 317,575 days of patient care under surveillance at this hospital. The rate of infection was 1.20 cases per 10,000 days of patient care under surveillance, compared to this hospital's national peer group performance of 1.00. This includes data from Royal Prince Alfred Institute of Rheumatology & Orthopaedics.

Year Cases Rate Peer group average Patient days under surveillance
In 2015–16 to 2017–18 data are included from Royal Prince Alfred Institute of Rheumatology & Orthopaedics
2017–18 38 1.20 1.00 317,575
2016–17 28 0.97 1.08 289,498
2015–16 38 1.40 1.02 270,474
2014–15 27 1.00 1.12 268,892
2013–14 34 1.28 1.32 265,263
2012–13 26 1.01 1.36 257,093
2011–12 27 1.05 1.41 256,375
2010–11 40 1.56 1.63 255,891

Healthcare-associated methicillin-resistant S. aureus (MRSA) bloodstream infections

An S. aureus bloodstream infection that is identified by a laboratory as being caused by methicillin-resistant S. aureus (MRSA) may cause more harm to patients and is associated with poorer outcomes as there are fewer antibiotics available to treat the infection.

In 2017–18, there were 8 cases of MRSA reported during 317,575 days of patient care under surveillance at this hospital. The rate of infection was 0.25 cases per 10,000 days of patient care under surveillance, compared to this hospital's national peer group performance of 0.18. This includes data from Royal Prince Alfred Institute of Rheumatology & Orthopaedics.

Year Cases Rate Peer group average Patient days under surveillance
In 2016–17 to 2017–18 data are included from Royal Prince Alfred Institute of Rheumatology & Orthopaedics
2017–18 8 0.25 0.18 317,575
2016–17 5 0.17 0.21 289,498

Healthcare-associated methicillin-sensitive S. aureus (MSSA) bloodstream infections

An S. aureus bloodstream infection that is identified by a laboratory as being caused by methicillin-sensitive S. aureus is referred to as MSSA.

In 2017–18, there were 30 cases of MSSA reported during 317,575 days of patient care under surveillance at this hospital. The rate of infection was 0.94 cases per 10,000 days of patient care under surveillance, compared to this hospital's national peer group performance of 0.81. This includes data from Royal Prince Alfred Institute of Rheumatology & Orthopaedics.

Year Cases Rate Peer group average Patient days under surveillance
In 2016–17 to 2017–18 data are included from Royal Prince Alfred Institute of Rheumatology & Orthopaedics
2017–18 30 0.94 0.81 317,575
2016–17 23 0.79 0.87 289,498